Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 287-370-9 | CAS number: 85480-89-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.02 mg/m³
- Most sensitive endpoint:
- carcinogenicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 55
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 1.1 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Ratio of assumed uptake from lung (100%) to known oral uptake (4%) from G.I. tract, therefore NOAEC to account for differences in uptake = 15/25. Correction for respiratory rate and volume (rat to human worker): (6.7m3/d/10m3/d) *(1/0.38 m3/kg) (default). Therefore the corrected NOAEC for repeated dose systemic effects via the inhalation route is: (15/25)/(6.7/10*1/0.38) = 0.6/1.76 = 1.1 mg/m3
- AF for dose response relationship:
- 10
- Justification:
- There is no specific guidance available on the value of an additional assessment factor for severity of effect. However, 10 is conservative and considered to be appropriate for the type of effects in this case (osteosarcoma).
- AF for differences in duration of exposure:
- 1
- Justification:
- Default (chronic study)
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Default (oral rat to inhaled human)
- AF for other interspecies differences:
- 2.5
- Justification:
- Default
- AF for intraspecies differences:
- 2.2
- Justification:
- The intraspecies assessment factor takes account for the variability in sensitivity between individuals. The human population is far more diverse than experimental animals that are bred to be as similar as possible, and unhealthy animals are not allowed to start the study. This AF also covers differences between ethnic groups and age groups. The default intraspecies factors are typically broken down into equal factors accounting for toxicodynamic and toxicokinetic differences, respectively. Accordingly, an intraspecies factor of 10 is composed of two identical factors of √10 = 3.2. Likewise, the default for workers (AF = 5) can be split into AFs of √5 = 2.2. Since enzymatic metabolism is not relevant for the osteosarcoma effect of EDTMP, individual genetic dispositions are therefore without effect on these processes. As a result, the toxicokinetic components (3.2 and 2.2 for general population and workers, respectively) can be eliminated from the intraspecies AF.
- AF for the quality of the whole database:
- 1
- Justification:
- Default (similar to guideline study)
- AF for remaining uncertainties:
- 1
- Justification:
- Default (no remaining uncertainties)
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.02 mg/m³
- Most sensitive endpoint:
- carcinogenicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 55
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.011 mg/kg bw/day
- Most sensitive endpoint:
- carcinogenicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 55
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 0.6 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- Ratio of assumed uptake from dermal (100%) to known oral uptake (4%) from G.I. tract, therefore NOAEL to account for differences in uptake = 15/25 = 0.6 mg/kg/day
- AF for dose response relationship:
- 10
- Justification:
- There is no specific guidance available on the value of an additional assessment factor for severity of effect. However, 10 is conservative and considered to be appropriate for the type of effects in this case (osteosarcoma).
- AF for differences in duration of exposure:
- 1
- Justification:
- Default (chronic study)
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Since the effect (osteosarcoma) is not as a result of metabolism, an assessment factor of 1 has been used for "correction for differences in metabolic rate per body weight" (instead of the default 4 value).
- AF for other interspecies differences:
- 2.5
- Justification:
- Default
- AF for intraspecies differences:
- 2.2
- Justification:
- The intraspecies assessment factor takes account for the variability in sensitivity between individuals. The human population is far more diverse than experimental animals that are bred to be as similar as possible, and unhealthy animals are not allowed to start the study. This AF also covers differences between ethnic groups and age groups. The default intraspecies factors are typically broken down into equal factors accounting for toxicodynamic and toxicokinetic differences, respectively. Accordingly, an intraspecies factor of 10 is composed of two identical factors of √10 = 3.2. Likewise, the default for workers (AF = 5) can be split into AFs of √5 = 2.2. Since enzymatic metabolism is not relevant for the osteosarcoma effect of EDTMP, individual genetic dispositions are therefore without effect on these processes. As a result, the toxicokinetic components (3.2 and 2.2 for general population and workers, respectively) can be eliminated from the intraspecies AF.
- AF for the quality of the whole database:
- 1
- Justification:
- Default (similar to guideline study)
- AF for remaining uncertainties:
- 1
- Justification:
- Default (no remaining uncertainties)
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.011 mg/kg bw/day
- Most sensitive endpoint:
- carcinogenicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 55
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
An oral DNEL for workers (relevant to ingestion following inhalation of dusts and aerosols) has been calculated.
The DNEL is 0.12 mg active acid/kg bw/day based on the development of osteosarcomas observed in a chronic/carcinogenicity study. The starting NOAEL is 15 mg active acid/kg bw/day with an assessment factor of 1 applied for duration; 2.5 for interspecies differences, and an assessment factor of 5 applied for intraspecies differences. In addition an assessment factor of 10 has been used to compensate for the severity of the effect. Since the effect is not as a result of metabolism, an assessment factor of 1 has been used for "correction for differences in metabolic rate per body weight" (instead of the default 4 value).
The calculated DNELs are valid for both the acid and salt EDTMP substances since once absorbed the EDTMP salts will dissociate to become the acid and counter-ion, while the counter-ion is not expected to exhibit or influence toxicity.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.006 mg/m³
- Most sensitive endpoint:
- carcinogenicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 80
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 0.52 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Ratio of assumed uptake from lung (100%) to known oral uptake (4%) from G.I. tract, therefore NOAEC to account for differences in uptake = 15/25. Correction for respiratory rate and volume (rat to human general population): (1/1.15 m3/kg) (default). Therefore the corrected NOAEC for repeated dose systemic effects via the inhalation route is: (15/25)/(1/1.15) = 0.6/0.87 = 0.52 mg/m3
- AF for dose response relationship:
- 10
- Justification:
- There is no specific guidance available on the value of an additional assessment factor for severity of effect. However, 10 is conservative and considered to be appropriate for the type of effects in this case (osteosarcoma).
- AF for differences in duration of exposure:
- 1
- Justification:
- Default (chronic study)
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Default (oral rat to inhaled human)
- AF for other interspecies differences:
- 2.5
- Justification:
- Default
- AF for intraspecies differences:
- 3.2
- Justification:
- The intraspecies assessment factor takes account for the variability in sensitivity between individuals. The human population is far more diverse than experimental animals that are bred to be as similar as possible, and unhealthy animals are not allowed to start the study. This AF also covers differences between ethnic groups and age groups. The default intraspecies factors are typically broken down into equal factors accounting for toxicodynamic and toxicokinetic differences, respectively. Accordingly, an intraspecies factor of 10 is composed of two identical factors of √10 = 3.2. Likewise, the default for workers (AF = 5) can be split into AFs of √5 = 2.2. Since enzymatic metabolism is not relevant for the osteosarcoma effect of EDTMP, individual genetic dispositions are therefore without effect on these processes. As a result, the toxicokinetic components (3.2 and 2.2 for general population and workers, respectively) can be eliminated from the intraspecies AF.
- AF for the quality of the whole database:
- 1
- Justification:
- Default (similar to guideline study)
- AF for remaining uncertainties:
- 1
- Justification:
- Default (no remaining uncertainties)
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.006 mg/m³
- Most sensitive endpoint:
- carcinogenicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 80
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.008 mg/kg bw/day
- Most sensitive endpoint:
- carcinogenicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 80
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 0.6 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- Ratio of assumed uptake from dermal (100%) to known oral uptake (4%) from G.I. tract, therefore NOAEL to account for differences in uptake = 15/25 = 0.6 mg/kg/day
- AF for dose response relationship:
- 10
- Justification:
- There is no specific guidance available on the value of an additional assessment factor for severity of effect. However, 10 is conservative and considered to be appropriate for the type of effects in this case (osteosarcoma).
- AF for differences in duration of exposure:
- 1
- Justification:
- Default (chronic study)
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Since the effect (osteosarcoma) is not as a result of metabolism, an assessment factor of 1 has been used for "correction for differences in metabolic rate per body weight" (instead of the default 4 value).
- AF for other interspecies differences:
- 2.5
- Justification:
- Default
- AF for intraspecies differences:
- 3.2
- Justification:
- The intraspecies assessment factor takes account for the variability in sensitivity between individuals. The human population is far more diverse than experimental animals that are bred to be as similar as possible, and unhealthy animals are not allowed to start the study. This AF also covers differences between ethnic groups and age groups. The default intraspecies factors are typically broken down into equal factors accounting for toxicodynamic and toxicokinetic differences, respectively. Accordingly, an intraspecies factor of 10 is composed of two identical factors of √10 = 3.2. Likewise, the default for workers (AF = 5) can be split into AFs of √5 = 2.2. Since enzymatic metabolism is not relevant for the osteosarcoma effect of EDTMP, individual genetic dispositions are therefore without effect on these processes. As a result, the toxicokinetic components (3.2 and 2.2 for general population and workers, respectively) can be eliminated from the intraspecies AF.
- AF for the quality of the whole database:
- 1
- Justification:
- Default (similar to guideline study)
- AF for remaining uncertainties:
- 1
- Justification:
- Default (no remaining uncertainties)
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.008 mg/kg bw/day
- Most sensitive endpoint:
- carcinogenicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 80
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
- Most sensitive endpoint:
- skin irritation/corrosion
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.19 mg/kg bw/day
- Most sensitive endpoint:
- carcinogenicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 80
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 15 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- Oral uptake is limited (4%) but no correction is made since both NOAEL and modelled exposure are external doses
- AF for dose response relationship:
- 10
- Justification:
- There is no specific guidance available on the value of an additional assessment factor for severity of effect. However, 10 is conservative and considered to be appropriate for the type of effects in this case (osteosarcoma).
- AF for differences in duration of exposure:
- 1
- Justification:
- Default (chronic study)
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- The substance is not metabolised prior to action, therefore the allometric scaling factor (AF = 4 for rat to human) is not used.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default
- AF for intraspecies differences:
- 3.2
- Justification:
- The intraspecies assessment factor takes account for the variability in sensitivity between individuals. The human population is far more diverse than experimental animals that are bred to be as similar as possible, and unhealthy animals are not allowed to start the study. This AF also covers differences between ethnic groups and age groups. The default intraspecies factors are typically broken down into equal factors accounting for toxicodynamic and toxicokinetic differences, respectively. Accordingly, an intraspecies factor of 10 is composed of two identical factors of √10 = 3.2. Likewise, the default for workers (AF = 5) can be split into AFs of √5 = 2.2. Since enzymatic metabolism is not relevant for the osteosarcoma effect of EDTMP, individual genetic dispositions are therefore without effect on these processes. As a result, the toxicokinetic components (3.2 and 2.2 for general population and workers, respectively) can be eliminated from the intraspecies AF.
- AF for the quality of the whole database:
- 1
- Justification:
- Default (similar to guideline study)
- AF for remaining uncertainties:
- 1
- Justification:
- Default (no remaining uncertainties)
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.19 mg/kg bw/day
- Most sensitive endpoint:
- carcinogenicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 80
- DNEL extrapolated from long term DNEL
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - General Population
The calculated DNELs are valid for both the EDTMP acid and salts since once absorbed the EDTMP salts will dissociate to become the acid and counter-ion, while the counter-ion is not expected to exhibit or influence toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
